Financial Highlights
Financial Highlights
Consolidated Results (IFRS)
(Unit: B JPY)
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|---|---|
| Revenue | 837.1 | 927.3 | 914.8 | 792.0 | 785.8 | 807.4 | 868.6 |
| Business income | 40.2 | 23.3 | 15.0 | 0.2 | (14.7) | (14.4) | 2.0 |
| Operating income | 37.6 | 14.7 | (55.4) | (11.7) | (21.0) | (11.5) | 3.4 |
| Net profit attributable to owners of the parent |
22.0 | 10.1 | (58.0) | (4.7) | (2.5) | (8.1) | 1.9 |
| Total assets | 929.3 | 877.5 | 952.4 | 939.6 | 867.1 | 826.7 | 844.8 |
| Total equity | 655.0 | 580.9 | 506.5 | 502.1 | 492.5 | 476.4 | 470.0 |
* We introduce “Business Income” as a measure of our underlying or recurring business performance after the adoption of IFRS. Business Income deducts cost of goods and SG&A from revenue, and includes other income and expenses which we believe are recurring in nature.
* In the fiscal year ending 31 December 2020, the Healthcare and Skincare business has been classified as a discontinued operation as a result of the decision to sell all shares in Q'sai held by the Company. As a result, revenue, business income and operating loss for 2020 is the amounts for continuing operations excluding discontinued operations.
* 2017 results are consolidated results of former CCW in the first quarter, and integrated results of CCBJH from April 1, 2017 to December 31, 2017.
